Experimental and Clinical Activity of Mitomycin C and cis-Diamminedichloroplatinum in Malignant Mesothelioma

A. Philippe Chahinian, Larry Norton, James F. Holland, Lenina Szrajer, Ronald D. Hart

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Little information is available regarding the effectiveness of chemotherapeutic agents in malignant mesothelioma. Human malignant mesothelioma specimens from two patients were successfully transplanted and maintained in homozygous nude mice. Screening of chemotherapeutic agents revealed that cisplatin was the most active single agent in one line, and mitomycin C in the other. The combination of mitomycin C and cisplatin, however, was the most effective regimen for both lines of xeno-grafted human mesothelioma. Based on these results in nude mice, a clinical trial of mitomycin C and cisplatin was undertaken. Four of 12 patients showed objective response (one complete and three partial). These clinical results support the usefulness of the nude mouse model for malignant mesothelioma.

Original languageEnglish
Pages (from-to)1688-1692
Number of pages5
JournalCancer Research
Volume44
Issue number4
StatePublished - 1 Apr 1984

Fingerprint

Dive into the research topics of 'Experimental and Clinical Activity of Mitomycin C and cis-Diamminedichloroplatinum in Malignant Mesothelioma'. Together they form a unique fingerprint.

Cite this